LIGAND PHARMACEUTICALS INC

SAN DIEGO, CA How do I update this listing?

Ligand Pharmaceuticals is based out of San Diego. Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that focuses on drug discovery and early-stage development of pharmaceuticals that address critical unmet medical needs or that are more effective and/or safer than existing therapies. The Company also has research and development collaborations for its product candidates with global pharmaceutical companies. These collaborations include ongoing clinical programs at Bristol-Myers Squibb (BMS), GlaxoSmithKline (GSK), Pfizer, Merck & Co. (Merck), Roche, Cephalon and Celgene. These partnered product candidates are being studied for the treatment of market indications, such as thrombocytopenia, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), asthma, osteoporosis, menopausal symptoms and Alzheimer's disease. On December 23, 2009, it acquired Neurogen Corporation (Neurogen).Whalewisdom has at least 9 13D filings, 5 13G filings, and 222 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2016-01-25. The notice included securities offered of Equity

Create Alert

Contact Info

ligand pharmaceuticals inc
3911 SORRENTO VALLEY BLVD
SAN DIEGO CA    92121

Business Phone: 858-550-7500
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Viking Therapeutics Inc (VKTX) HEALTH CARE 7,339,383 41,320,726.29 1 13D 2020-08-25

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2016-01-25 D PHARMACEUTICALS Equity 85,438,489 85,438,488 1
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
CHARLES S. BERKMAN subscription required
    DIRECTOR
DAVID M. KNOTT subscription required
    DIRECTOR
JASON ARYEH subscription required
    DIRECTOR
JOHN L. HIGGINS subscription required
    EXECUTIVE OFFICER DIRECTOR
JOHN KOZARICH subscription required
    DIRECTOR
JOHN LAMATTINA subscription required
    DIRECTOR
MATTHEW W. FOEHR subscription required
    DIRECTOR
MATTHEW KORENBERG subscription required
    DIRECTOR
MELANIE HERMAN subscription required
    DIRECTOR
STEPHEN SABBA subscription required
    DIRECTOR
SUNIL PATEL subscription required
    DIRECTOR
TODD DAVIS subscription required
    DIRECTOR

Elevate your investments